Sharps Compliance Corp. reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2017. For the quarter, the company reported revenue of $11,119,000 compared to $9,707,000 a year ago. Operating income was $107,000 compared to operating loss of $204,000 a year ago. Income before income tax benefit was $89,000 compared to loss before income tax benefit of $227,000 a year ago. Net income was $156,000 or $0.01 per basic and diluted share compared to net loss of $227,000 or $0.01 per basic and diluted share a year ago. EBITDA was $501,000 compared to $166,000 a year ago. Adjusted net income was $156,000 or $0.01 per diluted share compared to adjusted net loss of $227,000 or $0.01 per diluted share a year ago.

For the six months, the company reported revenue of $20,802,000 compared to $19,238,000 a year ago. Operating income was $208,000 compared to operating loss of $1,144,000 a year ago. Income before income tax benefit was $171,000 compared to loss before income tax benefit of $1,194,000 a year ago. Net income was $231,000 or $0.01 per basic and diluted share compared to net loss of $1,194,000 or $0.08 per basic and diluted share a year ago. EBITDA was $992,000 compared to EBITDA loss of $436,000 a year ago. Adjusted net income was $231,000 or $0.01 per diluted share compared to adjusted net loss of $492,000 or $0.03 per diluted share a year ago.

The company provided earnings guidance for the third quarter ending March 2018. The company believe the March 2018 quarter should be positively impacted from the continued growth in billings in all of its markets, including Retail where the company expects to see particularly strong growth in customer billings related to the unused medication management solutions. The company should also see third quarter gross margin levels more consistent with the 33% to 35% range. The company expects SG&A for the March 2018 quarter to be in the range of $2.8 million to $3 million.